NovoTTF-200A + Pembrolizumab In Melanoma Brain Metastasis

Clinical trial NCT04129515 · WITHDRAWN

Trial details

NCT number: NCT04129515
Sponsor: Brown University
Status: WITHDRAWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Metastatic Melanoma Melanoma Brain Metastasis

Start date: 2025-10-30
Primary completion: 2025-12-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.